Chargement de la fiche…
Chargement de la fiche…
Praticien hospitalier
Dans les médias
Vous êtes Dr Yannick Degboe ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Yannick Degboe est rhumatologue à Toulouse (31059). Il consulte à HOPITAL PURPAN CHU TOULOUSE, BAT PIERRE PAUL RIQUET — Place DU DR BAYLAC, 31059 Toulouse.
Consulter
HOPITAL PURPAN CHU TOULOUSE
BAT PIERRE PAUL RIQUET — Place DU DR BAYLAC, 31059 Toulouse
Dr Yannick Degboe, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Hospitalier
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine — Capacité / certificat d'études spéciales
2013–2026
Centre National de la Recherche Scientifique
2013–2026
Université Toulouse III - Paul Sabatier
2013–2026
Inserm
2014–2026
Centre Hospitalier Universitaire de Toulouse
2023
Assistance Publique – Hôpitaux de Paris
2019
Université de Bordeaux
travaux indexés
citations
h-index
i10
Indicateurs calculés par OpenAlex (base bibliographique ouverte) · ORCID 0000-0002-4293-8596.
Contenus publics où le nom du praticien apparaît (YouTube, Google Actualités).
En bref
Dr Yannick Degboe consulte à HOPITAL PURPAN CHU TOULOUSE, BAT PIERRE PAUL RIQUET — Place DU DR BAYLAC, 31059 Toulouse. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 05 61 77 22 33 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Rhumatologues à Toulouse →Rhumatologues en Haute-Garonne (31) →
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Toulouse, j'accompagne…
Exemple : vous choisissez vos propres domaines.
VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy
2025Frontiers in cardiovascular medicinePubMed
The serum levels of FGF23, sclerostin, osteoprotegerin do not explain the inverse relationship between coronary calcifications and bone mineral density evaluated using computed tomography
2025The journal of allergy and clinical immunology. In practicePubMed
Rheumatic adverse effects with biologics targeting type 2 inflammation in severe asthma: A VigiBase study
2024Frontiers in oncologyPubMed
Editorial: Immune-checkpoint inhibitors in anti-cancer armamentarium: a double-edged sword in risk of developing autoimmunity and immune-related adverse effects
2024Research in diagnostic and interventional imagingPubMed
Lumbar muscle involvement in the occurrence of osteoporotic vertebral fracture
2022Revue neurologiquePubMed
Loss of bone mineral density in hemiplegic patients after stroke: Prospective single-center study
2022International journal of molecular sciencesPubMed
Repolarization of Unbalanced Macrophages: Unmet Medical Need in Chronic Inflammation and Cancer
2021Rheumatology (Oxford, England)PubMed
Apremilast inhibits inflammatory osteoclastogenesis
2021iSciencePubMed
Evidence for tmTNF reverse signaling in vivo: Implications for an arginase-1-mediated therapeutic effect of TNF inhibitors during inflammation
2021JBMR plusPubMed
Hypophosphatasia: A Case of Two Patients With Spinal Cord Compression From Increase in Ligamentous Ossifications During Treatment
2020Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral ResearchPubMed
Inhibition of Osteoclastogenesis by the RNA-Binding Protein QKI5: a Novel Approach to Protect from Bone Resorption
2019Joint bone spinePubMed
Complex regional pain syndrome secondary to everolimus: Two cases
2019Frontiers in immunologyPubMed
Corrigendum: Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF/NF-κB-Dependent Mechanism
2019Frontiers in immunologyPubMed
Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF/NF-κB-Dependent Mechanism
2019Frontiers in immunologyPubMed
Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism
2019Allergology international : official journal of the Japanese Society of AllergologyPubMed
Mast cell activation syndrome: High frequency of skin manifestations and anaphylactic shock
2018BonePubMed
DKK1 and sclerostin are early markers of relapse in multiple myeloma
2025International journal of molecular sciencesPubMed
Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients
2025Diagnostics (Basel, Switzerland)PubMed
Predicting Clinical Response to Monoclonal TNF Inhibitors in Rheumatoid Arthritis: A Transcriptomic Approach Based on Transmembrane TNF Reverse Signaling and Nrf2 Activation
2025Annals of the rheumatic diseasesPubMed
Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial
2023Arthritis research & therapyPubMed
Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low disease activity
2026Joint bone spinePubMed
Strategies for denosumab discontinuation in postmenopausal osteoporosis
2025Current osteoporosis reportsPubMed
Management of Bone Health in Adult Mastocytosis
2024The journal of allergy and clinical immunology. In practicePubMed
The Prevalence Of Osteoporosis Is Low in Adult Cutaneous Mastocytosis Patients
2023JBMR plusPubMed
Discontinuation of Denosumab: Gradual Decrease in Doses Preserves Half of the Bone Mineral Density Gain at the Lumbar Spine
2026Joint bone spinePubMed
Uselessness of measuring anti-CD74 antibodies and Macrophage Migration Inhibitory Factor in axial spondyloarthritis patients in the DESIR cohort
2022Joint bone spinePubMed
Factors associated with drug-free remission at 5-year in early onset axial spondyloarthritis patients: Data from the DESIR cohort
2021Rheumatology (Oxford, England)PubMed
VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy
2020Clinical and experimental rheumatologyPubMed
Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes
2022Frontiers in medicinePubMed
Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study
2020Clinical and experimental rheumatologyPubMed
Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes
2019RMD openPubMed
Short-term risk of major adverse cardiovascular events or congestive heart failure in patients with psoriatic arthritis or psoriasis initiating a biological therapy: a meta-analysis of randomised controlled trials
2026LungPubMed
Asthma Reporting with Anti-TNFα Drugs used in Inflammatory Joint Diseases: A Vigibase® Study with Disproportionality Analysis
2020Journal of clinical medicinePubMed
Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis
2020Journal of clinical medicinePubMed
Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis
2019The pharmacogenomics journalPubMed
A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients
2024The Journal of infectionPubMed
Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registry
2019Journal of the European Academy of Dermatology and Venereology : JEADVPubMed
Frequency of isolated cutaneous involvement in adult mastocytosis: a cohort study
2022Frontiers in medicinePubMed
Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study
2020Archives of osteoporosisPubMed
No impact of anti-Rank ligand and PTH analogs on cardiovascular risk in postmenopausal osteoporosis: a systematic literature review and meta-analysis
2026 · Article
Strategies for denosumab discontinuation in postmenopausal osteoporosis
2025 · Article
Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients
2025 · Article
The serum levels of FGF23, sclerostin, osteoprotegerin do not explain the inverse relationship between coronary calcifications and bone mineral density evaluated using computed tomography
2025 · Article
Predicting Clinical Response to Monoclonal TNF Inhibitors in Rheumatoid Arthritis: A Transcriptomic Approach Based on Transmembrane TNF Reverse Signaling and Nrf2 Activation
2025 · Article
Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo-controlled, double-blind trial
2025 · Article
Management of Bone Health in Adult Mastocytosis
2025 · Article
Rheumatic adverse effects with biologics targeting type 2 inflammation in severe asthma: A VigiBase study
2024 · Article
Editorial: Immune-checkpoint inhibitors in anti-cancer armamentarium: a double-edged sword in risk of developing autoimmunity and immune-related adverse effects
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.
2020Bone reportsPubMed
Effect of risedronate on bone loss at discontinuation of denosumab